logo-loader
viewAmerican Express Company

American Express 3Q earnings beat analysts’ estimates; stock up 2% pre-market

The credit-card issuer said the higher-than-expected rise in its 3Q profit stemmed from more people using their cards to shop, pay bills and make big-ticket purchases

American Express Company - Americam Express Company (NYSE:AXP) reported third-quarter earnings Friday that beat analysts’ estimates
Net income rose to $1.76 billion, or $2.08 per share, while analysts had expected a profit of $2.03 per share

American Express Company (NYSE:AXP) reported third-quarter earnings Friday that beat analysts’ estimates. 

The credit-card issuer’s stock rose nearly 2% to $121.38 a share in New York in pre-market trading following the upbeat news. 

American Express said the higher-than-expected rise in its 3Q profit stemmed from more people using their credit cards to shop, pay bills and make big-ticket purchases. 

Net income rose to $1.76 billion, or $2.08 per share, in the quarter ended September 30, from $1.65 billion, or $1.88 per share, a year earlier, the company said. Analysts had expected a profit of $2.03 per share.

Total revenue, excluding interest expense, rose 8% to $11 billion, helped by higher customer spending, net interest income and card fees. Analysts had expected $10.95 billion in revenue. 

“The trends we saw in the business this quarter continue to be consistent with an economy that continues to grow, albeit at a more modest pace than last year,” Chief Executive Officer Steve Squeri said.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: American Express Company

Price: 131.52 USD

NYSE:AXP
Market: NYSE
Market Cap: $107.62 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 23 hours ago

2 min read